Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2021-005886-41Phase 2Completed
Phase 2 trial of bupivacaine in acute postoperative pain and postoperative pain, sponsored by Aarhus University Hospital. Primary endpoint: Accumulated opioid consumption. Started Jan 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2021-005886-41.